Stay updated with breaking news from Translational Sciences Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The grant was one of several TACTICAL awards — short for Therapy ACceleration To Intercept CAncer Lethality — given out by the Prostate Cancer Foundation.
The grant was one of several TACTICAL awards — short for Therapy ACceleration To Intercept CAncer Lethality — given out by the Prostate Cancer Foundation.
Recently published preclinical data by City of Hope scientists shows the immunotherapy is effective. Advanced ovarian cancer patients are now being enrolled in a Phase 1 first-in-human trial.
/PRNewswire/ -- There are currently few effective treatment options for patients with recurrent ovarian cancer and other solid tumors, but City of Hope...
/PRNewswire/ -- City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced it has received, along with...